Mounjaro (tirzepatide) is a medication approved by the FDA for managing type 2 diabetes. It works by improving blood sugar control and promoting weight loss.
No, Mounjaro is not currently approved for the treatment of prediabetes. It is specifically approved for individuals with type 2 diabetes.
While Mounjaro is not officially approved for prediabetes, some healthcare providers may prescribe it off-label for prediabetes management, especially in cases where weight loss and blood sugar control are critical. However, this is not common practice.
If you have prediabetes, the following strategies are recommended:
If you have prediabetes, it’s essential to consult your doctor to determine the best treatment plan for your specific needs.